We rank companies based on fund manager, research analyst and news sentiment
ASXC stock icon

Asensus Surgical


About: Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Employees: 209

Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

293% more call options, than puts

Call options by funds: $85.1K | Put options by funds: $21.7K

13% more capital invested

Capital invested by funds: $6.86M [Q3] → $7.78M (+$921K) [Q4]

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

0.4% less ownership

Funds ownership: 9.63% [Q3] → 9.24% (-0.4%) [Q4]

2% less funds holding

Funds holding: 65 [Q3] → 64 (-1) [Q4]

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Research analyst outlook

We haven’t received any recent analyst ratings for ASXC.

Financial journalist opinion